Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses After BCG Vaccination in Healthy Adults
NCT02413502Phase 1Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- May 2015
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 1, open-label, single-arm trial of bcg vaccine in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Primary endpoint: Immune response measured by Intracellular cytokine staining (ICS) at Day 56. Started May 2015; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02413502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413502.